Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2933
https://www.valueinhealthjournal.com/article/S1098-3015(15)05014-7/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
2340
First Page :
A756
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)05014-7&doi=10.1016/j.jval.2015.09.2933